Moreover, the fact that Lf can initiate receptor-mediated transcytosis through the BBB makes Lf a great choice as a protein for NP modification in drug delivery applications for reducing the progression of neurodegenerative diseases [65]. This evidence concerns the gene LTF and neurodegenerative disease.